Abstract

Genistein (GEN) has been previously reported to enhance the radiosensitivity of cancer cells; however, the detailed mechanisms remain unclear. Here, we report that GEN treatment inhibits the cytoplasmic distribution of Bcl-xL and increases nuclear Bcl-xL in non-small cell lung cancer (NSCLC). Interestingly, our in vitro data show that ionizing radiation IR treatment significantly increases IR-induced DNA damage and apoptosis in a low cytoplasmic Bcl-xL NSCLC cell line compared to that of high cytoplasmic Bcl-xL cell lines. In addition, clinical data also show that the level of cytoplasmic Bcl-xL was negatively associated with radiosensitivity in NSCLC. Furthermore, we demonstrated that GEN treatment enhanced the radiosensitivity of NSCLC cells partially due to increases in Beclin-1-mediated autophagy by promoting the dissociation of Bcl-xL and Beclin-1. Taken together, these findings suggest that GEN can significantly enhance radiosensitivity by increasing apoptosis and autophagy due to inhibition of cytoplasmic Bcl-xL distribution and the interaction of Bcl-xL and Beclin-1 in NSCLC cells, respectively.

Details

Title
Genistein promotes ionizing radiation-induced cell death by reducing cytoplasmic Bcl-xL levels in non-small cell lung cancer
Author
Zhang, Zhimin 1 ; Feng, Jin 1 ; Lian, Xiaojuan 2 ; Li, Mengxia 1 ; Wang, Ge 1 ; Lan, Baohua 1 ; He, Hao 1 ; Guo-Dong, Liu 3 ; Wu, Yan 1 ; Sun, Guiyin 2 ; Cheng-Xiong, Xu 1 ; Zhen-Zhou, Yang 1 

 Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China 
 Department of tumor blood, Jiangjin central hospital of Chongqing, Chongqing, China 
 Eighth Department, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China 
First page
1
Publication year
2018
Publication date
Jan 2018
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
1993416781
Copyright
© 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.